PFE:NYE-Pfizer Inc (USD)

COMMON STOCK | Drug Manufacturers - General |

Last Closing

USD 24.8

Change

0.00 (0.00)%

Market Cap

USD 163.54B

Volume

0.13B

Analyst Target

USD 41.79
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-16 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
LLY Eli Lilly and Company

N/A

USD 737.03B
NVO Novo Nordisk A/S

N/A

USD 499.24B
JNJ Johnson & Johnson

N/A

USD 380.12B
ABBV AbbVie Inc

N/A

USD 299.76B
BMY Bristol-Myers Squibb Company

N/A

USD 114.02B
OGN Organon & Co

N/A

USD 4.84B
GSK GlaxoSmithKline PLC ADR

N/A

N/A
MRK Merck & Company Inc

N/A

N/A
NVS Novartis AG ADR

N/A

N/A

ETFs Containing PFE

LIFE-U:CA Evolve Global Healthcare .. 5.25 % 0.00 %

N/A

N/A
THNR Amplify ETF Trust 5.24 % 0.00 %

N/A

USD 4.67M
HART IQ Healthy Hearts ETF 5.12 % 0.00 %

N/A

USD 8.74M
LIFE-B:CA Evolve Global Healthcare .. 5.06 % 0.00 %

N/A

N/A
W311:F HAN-GINS Indxx Healthcare.. 4.85 % 0.00 %

N/A

USD 0.02B
WELL:PA HAN-GINS Indxx Healthcare.. 4.85 % 0.00 %

N/A

N/A
WELL:SW HAN-GINS Indxx Healthcare.. 4.85 % 0.00 %

N/A

N/A
HVAX:CA 4.81 % 0.00 %

N/A

N/A
ZWHC:CA BMO Covered Call Health C.. 4.71 % 0.00 %

N/A

N/A
NXTV 4.65 % 0.00 %

N/A

N/A
MEDI Harbor Health Care ETF 4.49 % 0.00 %

N/A

USD 0.02B
TDIV:LSE VanEck Morningstar Develo.. 4.46 % 0.00 %

N/A

N/A
DURA 4.29 % 0.00 %

N/A

N/A
TDGB:LSE VanEck Morningstar Develo.. 4.23 % 0.00 %

N/A

USD 1.05B
TDIV:SW VanEck Morningstar Develo.. 4.17 % 0.00 %

N/A

USD 1.11B
MEDX Horizon Kinetics Medical .. 4.08 % 0.00 %

N/A

N/A
DVOP 4.04 % 0.00 %

N/A

N/A
ZWH:CA BMO US High Dividend Cove.. 3.87 % 0.71 %

N/A

CAD 1.06B
UVAL:SW SPDR® MSCI USA Value UCI.. 3.71 % 0.00 %

N/A

USD 0.14B
SCHD Schwab U.S. Dividend Equi.. 3.71 % 0.07 %

N/A

USD 65.68B
HEAL:CA 3.29 % 0.00 %

N/A

N/A
IUHC:SW iShares S&P 500 Health Ca.. 2.95 % 0.00 %

N/A

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 2.94 % 0.00 %

N/A

N/A
WMOT:XETRA VanEck Morningstar US Wid.. 2.56 % 0.00 %

N/A

N/A
IUVL:SW iShares Edge MSCI USA Val.. 2.45 % 0.00 %

N/A

USD 2.01B
ZYUS:AU ANZ S&P 500 High Yield Lo.. 2.30 % 0.00 %

N/A

USD 0.07B
XWVS:LSE Xtrackers MSCI World Valu.. 2.20 % 0.00 %

N/A

USD 8.44M
H41D:XETRA HSBC MSCI World Value ESG.. 2.17 % 0.00 %

N/A

N/A
CBUI:XETRA iShares MSCI World Value .. 2.15 % 0.00 %

N/A

USD 0.26B
VLUE:AU VanEck MSCI International.. 2.08 % 0.00 %

N/A

N/A
JHDV John Hancock Exchange Tra.. 2.00 % 0.00 %

N/A

N/A
BTC Grayscale Bitcoin Mini Tr.. 1.98 % 0.00 %

N/A

N/A
HWVS:LSE HSBC MSCI World Value ESG.. 1.89 % 0.00 %

N/A

USD 0.22B
GEDV:LSE SPDR® S&P® Global Divid.. 1.88 % 0.00 %

N/A

USD 0.02B
ZPD3:XETRA SPDR® S&P® Global Divid.. 1.87 % 0.00 %

N/A

USD 0.02B
GLDVD:SW UBS (Irl) ETF plc - S&P D.. 1.72 % 0.00 %

N/A

USD 0.11B
DIVG Invesco Exchange-Traded F.. 1.60 % 0.00 %

N/A

USD 2.85M
XDEV:SW Xtrackers MSCI World Valu.. 1.58 % 0.00 %

N/A

USD 1.93B
IWVL:SW iShares Edge MSCI World V.. 1.46 % 0.00 %

N/A

USD 3.79B
BSCJ 0.85 % 0.10 %

N/A

N/A
JEST:SW JPM EUR Ultra-Short Incom.. 0.73 % 0.00 %

N/A

USD 0.96B
SYBS:F SSgA SPDR ETFs Europe I P.. 0.39 % 0.00 %

N/A

USD 0.43B
SYBS:XETRA SSgA SPDR Barclays Cap St.. 0.39 % 0.00 %

N/A

USD 0.43B
CURE Direxion Daily Healthcare.. 0.00 % 1.06 %

N/A

USD 0.16B
CYH:CA iShares Global Monthly Di.. 0.00 % 0.66 %

N/A

CAD 0.15B
DEW WisdomTree Global High Di.. 0.00 % 0.58 %

N/A

N/A
DIVY Tidal ETF Trust 0.00 % 0.85 %

N/A

USD 0.01B
DVY iShares Select Dividend E.. 0.00 % 0.39 %

N/A

N/A
FDL First Trust Morningstar D.. 0.00 % 0.45 %

N/A

N/A
GNRX 0.00 % 0.55 %

N/A

N/A
IBDK 0.00 % 0.10 %

N/A

N/A
IHE iShares U.S. Pharmaceutic.. 0.00 % 0.42 %

N/A

N/A
IOO iShares Global 100 ETF 0.00 % 0.40 %

N/A

N/A
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

N/A

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
MOAT 0.00 % 0.49 %

N/A

N/A
MUS:CA 0.00 % 0.58 %

N/A

N/A
PEU.B:CA 0.00 % 1.16 %

N/A

N/A
PEY Invesco High Yield Equity.. 0.00 % 0.53 %

N/A

USD 1.22B
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

N/A

N/A
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

N/A

N/A
QDYN 0.00 % 0.37 %

N/A

N/A
RDIV Invesco S&P Ultra Dividen.. 0.00 % 0.39 %

N/A

N/A
RBUS 0.00 % 0.30 %

N/A

N/A
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

N/A

USD 0.02B
RWDC 0.00 % 0.00 %

N/A

N/A
ZWH-U:CA BMO US High Dividend Cove.. 0.00 % 0.00 %

N/A

N/A
PEU-B:CA 0.00 % 0.00 %

N/A

N/A
HID-B:CA 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

N/A

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

N/A

N/A
SHU:CA 0.00 % 0.70 %

N/A

N/A
SICK 0.00 % 0.95 %

N/A

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

N/A

N/A
VLUE 0.00 % 0.15 %

N/A

N/A
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

N/A

CAD 0.60B
XPH SPDR® S&P Pharmaceutical.. 0.00 % 0.35 %

N/A

N/A
DGR:CA 0.00 % 0.43 %

N/A

N/A
DFU:CA 0.00 % 0.59 %

N/A

N/A
XDGH:CA iShares Core MSCI Global .. 0.00 % 0.22 %

N/A

CAD 0.08B
XDUH:CA iShares Core MSCI US Qual.. 0.00 % 0.15 %

N/A

CAD 0.07B
ZVU:CA BMO MSCI USA Value ETF 0.00 % 0.33 %

N/A

CAD 0.06B
GBDV:LSE SPDR S&P Global Dividend .. 0.00 % 0.00 %

N/A

N/A
GLDV:LSE SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

N/A

N/A
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
IUVD:LSE iShares Edge MSCI USA Val.. 0.00 % 0.00 %

N/A

USD 0.11B
IUVF:LSE iShares Edge MSCI USA Val.. 0.00 % 0.00 %

N/A

USD 2.01B
IUVL:LSE iShares Edge MSCI USA Val.. 0.00 % 0.00 %

N/A

USD 2.01B
IWFV:LSE iShares MSCI World Value .. 0.00 % 0.00 %

N/A

USD 3.86B
IWVG:LSE iShares Edge MSCI World V.. 0.00 % 0.00 %

N/A

USD 0.13B
IWVL:LSE iShares Edge MSCI World V.. 0.00 % 0.00 %

N/A

USD 3.86B
IWVU:LSE iShares Edge MSCI World V.. 0.00 % 0.00 %

N/A

USD 0.13B
ISXF:LSE iShares Corporate Bond ex.. 0.00 % 0.00 %

N/A

USD 0.08B
LUMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

N/A
SLXX:LSE iShares Core £ Corp Bond.. 0.00 % 0.00 %

N/A

N/A
SSXF:LSE iShares III Public Limite.. 0.00 % 0.00 %

N/A

N/A
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

N/A
USMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

USD 0.01B
UVAL:LSE SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.14B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
WHEA:LSE SPDR® MSCI World Health .. 0.00 % 0.00 %

N/A

N/A
XDEV:LSE Xtrackers MSCI World Valu.. 0.00 % 0.00 %

N/A

N/A
XDND:LSE 0.00 % 0.00 %

N/A

N/A
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.00 %

N/A

N/A
XMEM:LSE Xtrackers MSCI Emerging M.. 0.00 % 0.00 %

N/A

N/A
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.65B
XSPD:LSE Xtrackers - S&P 500 Inver.. 0.00 % 0.00 %

N/A

USD 0.12B
XSPS:LSE Xtrackers S&P 500 Inverse.. 0.00 % 0.00 %

N/A

USD 0.12B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.65B
ZISG:LSE 0.00 % 0.00 %

N/A

N/A
USVL:LSE SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.14B
ZILS:LSE 0.00 % 0.00 %

N/A

N/A
MVUS:PA 0.00 % 0.00 %

N/A

N/A
MWO:PA Amundi FTSE EPRA/NAREIT G.. 0.00 % 0.00 %

N/A

USD 0.13B
SPMV:PA 0.00 % 0.00 %

N/A

N/A
DXS3:F Xtrackers - S&P 500 Inver.. 0.00 % 0.00 %

N/A

N/A
EXX5:F iShares Dow Jones U.S. Se.. 0.00 % 0.00 %

N/A

N/A
IS3S:F iShares Edge MSCI World V.. 0.00 % 0.00 %

N/A

N/A
JEST:F JPMorgan ETFs (Ireland) I.. 0.00 % 0.00 %

N/A

N/A
LMWE:F Lyxor FTSE EPRA/NAREIT Gl.. 0.00 % 0.00 %

N/A

N/A
OSX2:F Ossiam Lux - Ossiam US Mi.. 0.00 % 0.00 %

N/A

N/A
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
QDVI:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
UBUM:F UBS (Irl) ETF Public Limi.. 0.00 % 0.00 %

N/A

USD 0.11B
VDIV:F VanEck Vectors ETFs N.V... 0.00 % 0.00 %

N/A

USD 0.64B
XAIN:F Xtrackers - MSCI Indonesi.. 0.00 % 0.00 %

N/A

USD 0.05B
XDEV:F Xtrackers MSCI World Valu.. 0.00 % 0.00 %

N/A

USD 1.92B
XDWH:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

N/A

USD 2.60B
ZPRU:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.13B
XMDU:F 0.00 % 0.00 %

N/A

N/A
DXS3:XETRA Xtrackers - S&P 500 Inver.. 0.00 % 0.00 %

N/A

USD 0.12B
IS3S:XETRA iShares Edge MSCI World V.. 0.00 % 0.00 %

N/A

USD 3.97B
JEST:XETRA JPM EUR Ultra Short Incom.. 0.00 % 0.00 %

N/A

USD 0.86B
LMWE:XETRA Amundi FTSE EPRA/NAREIT G.. 0.00 % 0.00 %

N/A

USD 0.13B
OSX2:XETRA Ossiam US Minimum Varianc.. 0.00 % 0.00 %

N/A

USD 0.12B
QDVI:XETRA iShares Edge MSCI USA Val.. 0.00 % 0.00 %

N/A

USD 2.09B
UBUM:XETRA UBS (Irl) plc – DJ Glob.. 0.00 % 0.00 %

N/A

USD 0.17B
VDIV:XETRA VanEck Morningstar Develo.. 0.00 % 0.00 %

N/A

USD 0.64B
XAIN:XETRA Xtrackers - MSCI Indonesi.. 0.00 % 0.00 %

N/A

USD 0.05B
XDEV:XETRA Xtrackers MSCI World Valu.. 0.00 % 0.00 %

N/A

USD 1.60B
XDWH:XETRA Xtrackers MSCI World Heal.. 0.00 % 0.00 %

N/A

USD 2.60B
UIQM:XETRA 0.00 % 0.00 %

N/A

N/A
XMDU:XETRA 0.00 % 0.00 %

N/A

N/A
ZPRU:XETRA SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.13B
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
USDY 0.00 % 0.00 %

N/A

N/A
GBDV 0.00 % 0.00 %

N/A

N/A
W311:XETRA HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

N/A

USD 0.02B
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

N/A

USD 1.41B
QMJ 0.00 % 0.00 %

N/A

N/A
RAFE PIMCO RAFI ESG U.S. ETF P.. 0.00 % 0.00 %

N/A

USD 0.06B
HEAW:LSE SPDR® MSCI World Health .. 0.00 % 0.00 %

N/A

N/A
WHEA:SW SPDR MSCI World Health Ca.. 0.00 % 0.00 %

N/A

N/A
FOHW:XETRA Franklin Future of Health.. 0.00 % 0.00 %

N/A

USD 2.81M

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -13.86% 10% F 14% F
Dividend Return 5.84% 90% A- 78% C+
Total Return -8.02% 20% F 16% F
Trailing 12 Months  
Capital Gain -17.11% 10% F 10% F
Dividend Return 5.61% 90% A- 66% D+
Total Return -11.50% 10% F 11% F
Trailing 5 Years  
Capital Gain -29.88% 11% F 17% F
Dividend Return 22.40% 78% C+ 69% C-
Total Return -7.49% 11% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain -2.81% 30% F 21% F
Dividend Return 0.74% 30% F 26% F
Total Return 3.56% 70% C- 71% C-
Risk Return Profile  
Volatility (Standard Deviation) 26.68% 30% F 41% F
Risk Adjusted Return 2.79% 30% F 23% F
Market Capitalization 163.54B 43% F 99% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector